Comparative Study of Antinuclear Antibody Detection by Indirect Immunofluorescence and Enzyme Immunoassay in Lupus Patients

REFERENCES

• Alem, M., Moghadam, S., Malki, J., Zaidi, A., Nayak, N., Li, T.M. (1997): Detection of autoantibodies to nuclear antigens by EIA and IF techniques. Allerg. Immunol. 29(7):188, 191–194.
   PubMedGoogle Scholar
• Arbuckle, M.R., James, J.A., Kohlhase, K.F., Rubertone, M.V., Dennis, G.J., Harley, J.B. (2001). Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 54(1–2):211–219.
   PubMed Web of Science ®Google Scholar
• Arbuckle, M.R., McClain, M.T., Rubertone, M.V., Scofield, R.H., Dennis, G.J., James, J.A., Harley, J.B. (2003). Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349(16):1526–1533.
   PubMed Web of Science ®Google Scholar
• Berkem, R., Gümüş, T., Karakoç, E., Acar, N.. Berkem, R., Gümüş, T., Karakoç, E., Acar, N. (2003). Comparison of the methods used for the detection of antinuclear antibodies. Mikrobiyol. Bull. 37(2–3):171–178.
   PubMedGoogle Scholar
• Chen, C.Y., Tseng, H.M., Chen, L.C., Tsao, C.H., Kuo, M.L., Ou, L.S., Huang, J.L. (2003). Use of a new fluorescent immunoassay to detect anti-dsDNA antibodies are more correlated with disease activity and complement than the ELISA methods in SLE patients. Lupus 12(4):266–273.
   PubMed Web of Science ®Google Scholar
• Egner, W. (2000). The use of laboratory tests in the diagnosis of SLE. J. Clin. Pathol. 53(6):424–432.
   PubMed Web of Science ®Google Scholar
• Gniewek, R.A., Stites, D.P., McHugh, T.M., Hilton, J.F., Nakagawa, M. (1997). Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin. Diagn. Lab. Immunol. 4(2):185–188.
   PubMedGoogle Scholar
• González, B., Hernández, P., Olguín, H., Miranda, M., Lira, L., Toso, M., Quezada, A., Norambuena, X., Talesnik, E., Méndez, C., Navarrete C. (2005). Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus 14(11):918–923.
   PubMed Web of Science ®Google Scholar
• Gordon, C., Sutcliffe, N., Skan, J., Stoll, T., Isenberg, D.A. (2003). Definition and treatment of lupus flares measured by the BILAG index. Rheumatology 42:1372–1379.
   PubMed Web of Science ®Google Scholar
• Homburger, H.A., Cahen, Y.D., Griffiths, J., Jacob, G.L. (1998). Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescent methods. Arch. Pathol. Lab. Med. 122(11):993–999.
   PubMed Web of Science ®Google Scholar
• Isenberg, D.A., Gordon, C. (2000). From BILAG to BLIPS—Disease activity assessment in lupus: past, present and future. Lupus 9:651–654.
   PubMed Web of Science ®Google Scholar
• Janyapoon, K., Jivakanont, P., Choosang, K., Surbrsing, R., Charoenying, V., Baithong, S. (2003). Comparative study of anti-double stranded DNA detection by ELISA and Crithidia luciliae immunofluorescence. Southeast. Asian J. Trop. Med. Public Health 34(3):646–650.
   PubMedGoogle Scholar
• Kang, I., Siperstein, R., Quan, T., Breitenstein, M.L. (2004). Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and anti-dsDNA antibodies. Clin. Rheumatol. 23(6):509–515.
   PubMed Web of Science ®Google Scholar
• Kavanaugh, A., Tomar, R., Reveille, J., Solomon, D.H., Homburger, H.A. (2000): Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch. Pathol. Lab. Med. 124(1):71–81.
   PubMed Web of Science ®Google Scholar
• Lam, G.K., Petri, M (2005). Assessment of systemic lupus erythematosus. Clin. Exp. Rheumatol. 23(5 Suppl 39):S120–132.
   PubMed Web of Science ®Google Scholar
• Linnik, M.D., Hu, J.Z., Heilbrunn, K.R., Strand, V., Hurley, F.L., Joh, T., LJP 394 Investigator Consortium. (2005). Relationship between anti-dsDNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Chin. Med. J. 12(11):827–832.
   Google Scholar
• McMahon, M., Kalunian, K. (2004). SLE-associated tests. In Lotze, M., Thomson, A., eds. Measuring Immunity, Basic Biology and Clinical Assessment, Chapter 17, Academic Press, USA; 210–220.
   Google Scholar
• Peene, I., Meheus, L., Veys, E.M., De Keyser, F. (2001). Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples refereed for ANA testing. Ann. Rheum. Dis. 60(12): 1131–1136.
   PubMed Web of Science ®Google Scholar
• Putterman, C. (2004). New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun. Rev. 3(2):7–11.
   PubMed Web of Science ®Google Scholar
• Reisner, B.S., DiBlasi, J. Goel, N. (1999). Comparison of an enzyme immunoassay to an indirect fluorescent immunoassay for the detection of antinuclear antibodies. Am. J. Clin. Pathol. 111(4):503–506.
   PubMed Web of Science ®Google Scholar
• Riboldi, P., Gerosa, M., Moroni, G., Radice, A., Allegri, F., Sinico, A., Tincani, A., Meroni, P.L. (2005). Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 38(1):39–45.
   PubMed Web of Science ®Google Scholar
• Sherer, Y., Gorstein, A., Fritzler, M.J., Shoenfeld, Y. (2004). Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum. 35(1):65.
   Google Scholar
• Singh, J.A., Solomon, D.H., Dougados, M., Felson, D., Hawker, G., Katz, P., Paulus, H., Wallace, C. Classification and Response Criteria Subcommittee of the Committee on Quality Measures, American College of Rheumatology (2006): Development of classification and response criteria for rheumatic diseases. Arthritis Rheum. June 15; 55(3):348–352.
   PubMed Web of Science ®Google Scholar
• Singh, R.R., Malaviya, A.N., Kailash, S., Varghese, T. (1991). Clinical significance of anti-Sm antibody in systemic lupus erythematosus and related disorders. Ind. J. Med. Res. 94:206–210.
   PubMed Web of Science ®Google Scholar
• Swaak, A.J.G., Aarden, L.A., Statius van Eps, L.W., Feltkamp, T.E.W. (1979). Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 22:226–235.
   PubMed Web of Science ®Google Scholar
• ter Borg, E.J., Horst, G., Hummel, E.J., Limburg, P.C., Kallenberg, C.G.M. (1990). Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 33:634–643.
   PubMed Web of Science ®Google Scholar
• Tonuttia, E., Bassetti, D., Piazza, A., Visentini, D., Poletto, M., Bassetto, F., Caciagli, P., Villalta, D., Tozzoli, R., Bizzaro, N. (2004). Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 37(2):171–176.
   PubMed Web of Science ®Google Scholar
• Ulvestad, E., Kanestrøm, A., Madland, T.M., Thomassen, E., Haga, H.J., Vollset, S.E. (2000). Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand. J. Immunol. 52(3):309.
   PubMed Web of Science ®Google Scholar
• Yilmaz, O., Karaman, M., Ergon M.C., Bahar, I.H., Yuluğ, N. (2004). Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies. Mikrobiyol Bull. 38(1–2):85–90.
   PubMedGoogle Scholar